Aviceda Therapeutics (“Aviceda”), a private, clinical-stage biotech company announced the closing of a $207.5 million Series C financing. Proceeds will support the ongoing Phase 2b/3 and planned pivotal Phase 3 clinical trial for AVD-104 in geographic atrophy (GA), a vision-threatening condition secondary to advanced age-related macular degeneration, and the expansion into other ophthalmic indications.
Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney, and bladder cancer, announced the completion of the company’s oversubscribed $80 million Series C equity financing, the largest fundraising round to date for the company.
Twentyeight Health, the leading digital-first women's healthcare platform delivering convenient, affordable, and stigma-free reproductive and sexual care in 43 states, announces $10 million in Series A funding led by Seae Ventures, with participation from Impact America Fund, The Social Entrepreneurs' Fund, RH Capital, Impact Engine, Gratitude Railroad, and Townhall Ventures.
Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, announced the closing of a Series C funding round raising $105 million.
Rembrand, the leading innovator in In-Scene Media and Virtual Product Placement technology, has raised $23 million in Series A financing to expand and fuel the already rapid growth of the company.
Plume announce a new $20M Series A funding round from both leading crypto & traditional financial institutions: Brevan Howard Digital, Lightspeed Faction, Haun Ventures, Galaxy Ventures, Hashkey, Laser Digital (Nomura Group), 280 Capital, Superscrypt, A Capital, SV Angel, Reciprocal Ventures, and others.
Mojave Energy Systems, founded to change the nature of air conditioning, has raised $9.5 million in Series A funding. The Series A round was led by existing investors Fifth Wall and At One Ventures, with participation from returning investors Myriad Venture Partners, Starshot Capital, Alumni Ventures Group, and new investor Earth Venture Capital.
ŌURA, the company behind Oura Ring, the world’s leading smart ring, announced the completion of a $200 million Series D funding round. Fidelity Management & Research Company and Dexcom, the global leader in glucose biosensing, participated in the round. The investment raises the company’s valuation to $5.2 billion.
Borealis Biosciences, a next-generation RNA medicines company, today announced the appointment of Christian Hordo as CEO; a $30 million infusion from an extension of the Series A led by Westlake BioPartners; and the addition of three new board directors, David Allison, Ph.D., Tom Frohlich and Catherine Thut, Ph.D.
Chargezoom, a leading platform for AI-powered billing and integrated payments, announced today it has raised $11.5 million in Series A funding, led by Salt Lake City’s Kickstart Fund.
